David Brusick

4.8k total citations
117 papers, 3.6k citations indexed

About

David Brusick is a scholar working on Cancer Research, Molecular Biology and Plant Science. According to data from OpenAlex, David Brusick has authored 117 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Cancer Research, 38 papers in Molecular Biology and 35 papers in Plant Science. Recurrent topics in David Brusick's work include Carcinogens and Genotoxicity Assessment (65 papers), Genetically Modified Organisms Research (18 papers) and DNA Repair Mechanisms (14 papers). David Brusick is often cited by papers focused on Carcinogens and Genotoxicity Assessment (65 papers), Genetically Modified Organisms Research (18 papers) and DNA Repair Mechanisms (14 papers). David Brusick collaborates with scholars based in United States, Canada and United Kingdom. David Brusick's co-authors include Vincent F. Simmon, M. C. Carakostas, Virginia C. Dunkel, Kristien Mortelmans, Leslie L. Curry, Amy C. Boileau, Herbert S. Rosenkranz, Errol Zeiger, B. Myhr and Kerry L. Dearfield and has published in prestigious journals such as Journal of Bacteriology, Environmental Health Perspectives and Chemosphere.

In The Last Decade

David Brusick

109 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Brusick United States 31 1.7k 1.0k 1.0k 826 525 117 3.6k
Benoı̂t Schilter Switzerland 37 1.0k 0.6× 1.4k 1.3× 1.1k 1.1× 1.0k 1.2× 729 1.4× 101 4.5k
Motoi Ishidate Japan 23 1.6k 1.0× 535 0.5× 912 0.9× 830 1.0× 232 0.4× 49 2.5k
Luc Verschaeve Belgium 38 1.1k 0.7× 1.1k 1.1× 1.0k 1.0× 1.1k 1.3× 633 1.2× 175 4.6k
David Kirkland United Kingdom 41 2.9k 1.8× 1.4k 1.4× 1.6k 1.5× 1.7k 2.1× 308 0.6× 140 5.3k
John Doull United States 29 419 0.3× 577 0.6× 581 0.6× 789 1.0× 541 1.0× 96 3.1k
Daniel Marzin France 30 1.0k 0.6× 615 0.6× 840 0.8× 775 0.9× 139 0.3× 85 2.9k
F.E. Würgler Switzerland 33 1.5k 0.9× 1.4k 1.3× 2.1k 2.1× 750 0.9× 287 0.5× 125 4.1k
Steve Haworth United States 16 1.6k 1.0× 578 0.6× 618 0.6× 926 1.1× 306 0.6× 18 2.5k
Kerry L. Dearfield United States 31 1.4k 0.8× 935 0.9× 744 0.7× 816 1.0× 649 1.2× 71 2.9k
Jay I. Goodman United States 35 1.0k 0.6× 432 0.4× 1.7k 1.7× 611 0.7× 500 1.0× 110 3.6k

Countries citing papers authored by David Brusick

Since Specialization
Citations

This map shows the geographic impact of David Brusick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Brusick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Brusick more than expected).

Fields of papers citing papers by David Brusick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Brusick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Brusick. The network helps show where David Brusick may publish in the future.

Co-authorship network of co-authors of David Brusick

This figure shows the co-authorship network connecting the top 25 collaborators of David Brusick. A scholar is included among the top collaborators of David Brusick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Brusick. David Brusick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Custer, Laura, et al.. (1993). Detection of chemical mutagens using Muta® Mouse: a transgenic mouse model. Mutagenesis. 8(1). 7–10. 76 indexed citations
3.
Brusick, David. (1992). Assessing the risk of genetic damage. 6 indexed citations
4.
Brusick, David, et al.. (1992). Genotoxicity hazard assessment of Caramel Colours III and IV. Food and Chemical Toxicology. 30(5). 403–410. 19 indexed citations
5.
Brusick, David, J. Ashby, Frederick J. de Serres, et al.. (1992). A method for combining and comparing short-term genotoxicity test data: Preface. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 266(1). 1–6. 22 indexed citations
6.
Lohman, P.H.M., M.L. Mendelsohn, Dan H. Moore, et al.. (1992). A method for comparing and combining short-term genotoxicity test data: The basic system. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 266(1). 7–25. 27 indexed citations
7.
Brusick, David. (1991). A proposed method for assembly and interpretation of short-term test data.. Environmental Health Perspectives. 96. 101–111. 4 indexed citations
8.
Brusick, David, et al.. (1989). Assessment of the genotoxicity of calcium cyclamate and cyclohexylamine. Environmental and Molecular Mutagenesis. 14(3). 188–199. 12 indexed citations
9.
Brusick, David, et al.. (1982). Genetic properties of benzophenone 2 in a battery of short term assays. Environmental Mutagenesis. 4(3). 398. 1 indexed citations
10.
Brusick, David, et al.. (1980). Genetic activity of para formaldehyde in the ames assay the l 5178y mouse lymphoma assay the cho sister chromatid exchange assay and in an in vitro cho chromosome analysis. Environmental Mutagenesis. 2(2). 253. 1 indexed citations
11.
Brusick, David & Dale W. Matheson. (1978). Mutagen and Oncogen Study on 1-Methylaminoanthraquinone. Defense Technical Information Center (DTIC). 1 indexed citations
12.
Brusick, David. (1978). Alteractions of germ cells leading to mutagenesis and their detection. Environmental Health Perspectives. 24. 105–112. 5 indexed citations
13.
Brusick, David, et al.. (1976). The utilization of in vitro mutagenesis techniques to explain strain, age and sex related differences in dimethylnitrosamine tumor susceptibilities in mice. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 41(1). 51–59. 20 indexed citations
14.
Mayer, V.W., et al.. (1976). Genetic effects induced in Sacharomyces cerevisiae by cyclophosphamide in vitro without liver enzyme preparations. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 37(2-3). 201–212. 19 indexed citations
15.
Brusick, David, et al.. (1975). In vitro metabolic activation of chemical mutagens. I. Development of an in vitro mutagenicity assay liver microsomal enzymes for the activation of dimethylnitrosamine to a mutagen. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 28(1). 113–122. 27 indexed citations
17.
Brusick, David. (1972). The mutagenic activity of β-propiolactone in Saccharomyces cerevisiae. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 15(4). 425–434. 5 indexed citations
18.
Brusick, David & Errol Zeiger. (1972). A comparison of chemically induced reversion patterns of salmonella typhimurium and saccharomyces cerevisiae mutants, using in vitro plate tests. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 14(3). 271–275. 32 indexed citations
19.
Brusick, David. (1970). The mutagenic activity of ICR-170 in Saccharomyces cerevisiae. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 10(1). 11–19. 37 indexed citations
20.
Brusick, David. (1969). Reversion of acridine mustard-induced ad-3 mutants of Neurospora crassa. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 8(2). 247–254. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026